Abstract 4367840: Optimizing the Accuracy of Natural Language Processing Models for Pulmonary Embolism Detection Through Integration with Claims Data: The PE-EHR+ Study

S Sina Rashedi (Thrombosis Research Group, Brigham and Women’s Hospital–Harvard Medical School, Boston) S Syed Bukhari (Johns Hopkins School of Medicine, Baltimore, Maryland, United States) D Darsiya Krishnathasan (Thrombosis Research Group, Brigham and Women’s Hospital–Harvard Medical School, Boston) C Candrika Khairani (Rochester General Hospital, Rochester, New York, United States) A Antoine Bejjani (Thrombosis Research Group, Brigham and Women’s Hospital–Harvard Medical School, Boston) M Mariana Pfeferman (Thrombosis Research Group, Brigham and Women’s Hospital–Harvard Medical School, Boston) M Mehrdad Zarghami (Jamaica Hospital, New York, New York, United States) E Eric Secemsky (Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States) F Farbod Rahaghi (Harvard School of Medicine, Boston, Massachusetts, United States) M Mohamad Hussain (Brigham and Womens Hospital, Boston, Massachusetts, United States) H HAMID MOJIBIAN (Yale School of Medicine, NEW HAVEN, New York, United States) S Samuel Goldhaber (Brigham and Women's Hospital, Boston, Massachusetts, United States) L Li Zhou R Richard Yang (Brigham and Women's Hospital, Boston, Massachusetts, United States) L Liqin Wang (State Key Laboratory of Oncology in South China, Department of Experimental Research, Sun Yat-sen University Cancer Center) H Harlan Krumholz (Yale School of Medicine, New Haven, Connecticut, United States) G Gregory Piazza (Thrombosis Research Group, Brigham and Women’s Hospital, Harvard Medical School, Boston) B Behnood Bikdeli (Thrombosis Research Group, Brigham and Women’s Hospital–Harvard Medical School, Boston)

Abstract

Background: Rule-based natural language processing (NLP) tools are easy to implement and can identify pulmonary embolism (PE) via radiology reports, but their accuracy is limited when used in isolation, and their external validity remains uncertain. Methods: In this cross-sectional study, we analyzed data from a prespecified sample of 1,712 hospitalized patients (with and without PE) at Mass General Brigham (MGB) hospitals (2016–2021) and applied two previously published NLP algorithms (Verma et al. and Johnson et al) to radiology reports to identify PE. Chart review by two independent physicians using pre-specified criteria was the reference standard. We tested three approaches: (A) NLP applied to all patients; (B) NLP limited to patients with primary or secondary International Classification of Diseases (ICD)-10 PE discharge codes; and (C) NLP applied to patients with PE discharge codes or a Present-on-Admission (POA) indicator (“Y” or “N”) for PE. All others were assumed PE-negative in Approaches B and C to minimize false positives with NLP. Weighted estimates were derived from the full MGB hospitalized cohort (n=381,642) to calculate F1 scores that summarize model performance by combining sensitivity and positive predictive value (PPV) [F1 = 2 x (PPV x sensitivity)/ (PPV + sensitivity)]. Results: In total, 7,708 (2.0%) patients had PE. In Approach A, both NLP models showed high sensitivity (82.5%, 93.0%) and specificity (98.9%, 98.7%) but low PPV (60.3%, 59.6%) (Figure). Approach B improved PPV (95.2%, 94.9%) at the cost of reduced sensitivity (74.1%, 76.2%), while Approach C preserved both high sensitivity (82.5%, 93.0%) and PPV (95.6%, 95.8%). Approach C demonstrated the best performance, yielding significantly higher F1 scores for both NLP models (88.6%, 94.4%) compared with Approach A (69.7%, 72.6%) and Approach B (83.3%, 84.5%) (P<0.001). Conclusions: The accuracy of PE detection improves when rule-based NLP models are operationalized within a screening framework using administrative claims data in addition to radiology reports.

Article Details

Journal Circulation
Volume / Issue Vol. 152, Issue Suppl_3
Published November 04, 2025
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (18)

S

Sina Rashedi

Thrombosis Research Group, Brigham and Women’s Hospital–Harvard Medical School, Boston

S

Syed Bukhari

Johns Hopkins School of Medicine, Baltimore, Maryland, United States

D

Darsiya Krishnathasan

Thrombosis Research Group, Brigham and Women’s Hospital–Harvard Medical School, Boston

C

Candrika Khairani

Rochester General Hospital, Rochester, New York, United States

A

Antoine Bejjani

Thrombosis Research Group, Brigham and Women’s Hospital–Harvard Medical School, Boston

M

Mariana Pfeferman

Thrombosis Research Group, Brigham and Women’s Hospital–Harvard Medical School, Boston

M

Mehrdad Zarghami

Jamaica Hospital, New York, New York, United States

E

Eric Secemsky

Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States

F

Farbod Rahaghi

Harvard School of Medicine, Boston, Massachusetts, United States

M

Mohamad Hussain

Brigham and Womens Hospital, Boston, Massachusetts, United States

H

HAMID MOJIBIAN

Yale School of Medicine, NEW HAVEN, New York, United States

S

Samuel Goldhaber

Brigham and Women's Hospital, Boston, Massachusetts, United States

L

Li Zhou

R

Richard Yang

Brigham and Women's Hospital, Boston, Massachusetts, United States

L

Liqin Wang

State Key Laboratory of Oncology in South China, Department of Experimental Research, Sun Yat-sen University Cancer Center

H

Harlan Krumholz

Yale School of Medicine, New Haven, Connecticut, United States

G

Gregory Piazza

Thrombosis Research Group, Brigham and Women’s Hospital, Harvard Medical School, Boston

B

Behnood Bikdeli

Thrombosis Research Group, Brigham and Women’s Hospital–Harvard Medical School, Boston